MedPath
HSA Approval

APO-IBUPROFEN-FC TABLET 400 mg

SIN06017P

APO-IBUPROFEN-FC TABLET 400 mg

APO-IBUPROFEN-FC TABLET 400 mg

June 3, 1991

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

M01AE01

ibuprofen

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

IBUPROFEN

400 mg

Ibuprofen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-IBUPROFEN-FC TABLET 400 mg - HSA Approval | MedPath